Search results
Results from the WOW.Com Content Network
[1] [2] [3] The PHQ-9 is a component of the larger self-administered Patient Health Questionnaire (PHQ), but can be used as a stand-alone instrument. [4] The PHQ is part of Pfizer's larger suite of trademarked products, called the Primary Care Evaluation of Mental Disorders (PRIME-MD). [5] The PHQ-9 takes less than three minutes to complete.
The PHQ-9, GAD-7, and the PHQ-15 were combined to create the PHQ-somatic, anxiety, depressive symptoms (PHQ-SADS) [2] and includes questions regarding panic attacks (after the GAD-7 section). Though less commonly used, there are also brief versions of the PHQ-9 and GAD-7 that may be useful as screening tools in some settings.
The Patient Health Questionnaire (PHQ) sets are self-reported depression rating scales. For example, the Patient Health Questionnaire-9 is a self-reported, 9-question version of the Primary Care Evaluation of Mental Disorders. [16]
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.
The patient is rated by a clinician on 17 to 29 items (depending on version) scored either on a 3-point or 5-point Likert-type scale. For the 17-item version, a score of 0–7 is considered to be normal while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial. [11]
PSYCHLOPS is a mental health outcome-measure tool used in primary care or community care settings and is self-completed. It measures mental health problems, quality of life, social functioning and wellbeing.
Major depressive episodes are known to cause sleep disturbances such as insomnia [3] or, less frequently, hypersomnia. [9] Symptoms of insomnia include trouble falling asleep, trouble staying asleep, or waking up too early in the morning. [3] Hypersomnia may include sleeping for prolonged periods at night or increased sleeping during the ...
The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item [1] diagnostic questionnaire which mental health professionals use to measure the severity of depressive episodes in patients with mood disorders.